Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers

Published:2020-07-03 Issue:4 Volume:26 Page:2577-2585
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Niu Dongfeng,Li Lei,Yu Yang,Zang Wanchun,Li Zhongwu,Zhou Lixin,Jia Ling,Rao Guanhua,Gao Lianju,Cheng Gang,Ji Ke,Lin Dongmei

Funder

Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12253-020-00844-w.pdf

Reference17 articles.

1. Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr, Wu YL, Paz-Ares L (2017) Lung cancer: current therapies and new targeted treatments. Lancet 389(10066):299–311. https://doi.org/10.1016/S0140-6736(16)30958-8

2. Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, Friez MJ, Funke BH, Hegde MR, Lyon E, Working Group of the American College of Medical G, Genomics Laboratory Quality Assurance C (2013) ACMG clinical laboratory standards for next-generation sequencing. Genet Med 15(9):733–747. https://doi.org/10.1038/gim.2013.92

3. Hamblin A, Wordsworth S, Fermont JM, Page S, Kaur K, Camps C, Kaisaki P, Gupta A, Talbot D, Middleton M, Henderson S, Cutts A, Vavoulis DV, Housby N, Tomlinson I, Taylor JC, Schuh A (2017) Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: retrospective validation and prospective audit in the UK National Health Service. PLoS Med 14(2):e1002230. https://doi.org/10.1371/journal.pmed.1002230

4. Pfarr N, Penzel R, Endris V, Lier C, Flechtenmacher C, Volckmar AL, Kirchner M, Budczies J, Leichsenring J, Herpel E, Noske A, Weichert W, Schneeweiss A, Schirmacher P, Sinn HP, Stenzinger A (2017) Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance. Gene Chromosome Cancer 56(4):255–265. https://doi.org/10.1002/gcc.22431

5. Yamamoto T, Shimojima K, Ondo Y, Imai K, Chong PF, Kira R, Amemiya M, Saito A, Okamoto N (2016) Challenges in detecting genomic copy number aberrations using next-generation sequencing data and the eXome hidden Markov model: a clinical exome-first diagnostic approach. Hum Genome Var 3:16025. https://doi.org/10.1038/hgv.2016.25

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance to Anti-HER2 Therapies in Gastrointestinal Malignancies;Cancers;2024-08-15

2. Comparative Analysis of Gut Microbiota between Captive and Wild Long-Tailed Gorals for Ex Situ Conservation;Microorganisms;2024-07-12

3. Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives;European Journal of Cancer;2024-03

4. HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancer;American Journal of Clinical Pathology;2023-12-16

5. Comparison of an amplicon-based large panel next generation sequencing (NGS) assay with conventional testing methods for MET and HER2 amplification in lung and breast cancers;Pathology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3